In this study, we eliminated the ability of FMN to reduce excessive ROS generation in the MPP(+)-induced C. elegans PD model, utilizing a fluorescent dihydroethidium (DHE) probe to evaluate ROS levels. This evidence concerns the gene FMN1 and Parkinson disease.